DZ Medicale is a legacy medical‑sector company that, before Kredo’s intervention, went through a gradual loss of direction. After being sold to foreign investors about seven years ago, the company was perceived negatively by the market: weakened identity, unclear positioning, and management still tied to the founder’s personal dynamics.
The handover to new governance marked a critical moment. CEO Ing. Filippo Conforti inherited a company with strong industrial capabilities, but without a strategic structure capable of supporting its evolution.
It is in this context that collaboration with Kredo begins: not as a cosmetic intervention, but as a progressive reconstruction path.

